Adverse effects and zimelidine therapy. Headache, muscle pain and liver involvement--a new disease entity in zimelidine therapy
Paulsen, O.; Nilsson, L.M.; Sellin, M.; Osterlind, A.; Lundgren, M.; Fahlesson, P.
Lakartidningen 80(1-2): 31-32
1983
ISSN/ISBN: 0023-7205 PMID: 6220186 Document Number: 220718
Document emailed within 1 workday
Related Documents
Gehlen, W. 1980: Adverse effects of drug therapy in Parkinson disease Medizinische Monatsschrift für Pharmazeuten 3(4): 104-110Reust, C.E. 2011: Common adverse effects of antiretroviral therapy for HIV disease American Family Physician 83(12): 1443-1451
Bermejo, F.; Martínez, P.; de Yébenes, J.G. 1986: Parkinson disease, adverse effects of chronic levodopa therapy and drug holidays Archivos de Neurobiologia 49(5): 300-302
Croft, A.M.; Herxheimer, A. 2002: Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement? Bmc Public Health 2: 6
Hilliquin, P.; Menkès, C.J.; Laoussadi, S.; Job-Deslandre, C.; Serratrice, G. 1992: Camptocormia in the elderly. a new entity by paravertebral muscle involvement? Revue du Rhumatisme et des Maladies Osteo-Articulaires 59(3): 169-175
Drèze, C. 1977: Liver involvement in mehtyldopa therapy Revue Medicale de Liege 32(15): 457-458
Gossius, G. 1986: Adverse effects in trimethoprim therapy Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(2): 147-149
Cleator, I.G. 1983: Adverse effects of ranitidine therapy Canadian Medical Association Journal 129(5): 405
Halparin, L.S. 1984: Adverse effects of ranitidine therapy Canadian Medical Association Journal 130(6): 668; 672
Ramachandran, S. 1973: Adverse effects of emetine therapy Ceylon Medical Journal 18(3): 138-143
Erbeck, D.H.; Hagee, J.H. 1974: A successful course of therapy for necrotic colitis, a newly recognized disease entity of cats Veterinary Medicine-Small Animal Clinician 69(5): 603-605
Mickley, H.; Amtrup, F. 1981: Liver involvement during tolphenamic acid therapy Ugeskrift for Laeger 143(32): 2036-2037
Fukuda, T. 2010: The efficacy of enzyme replacement therapy in pompe disease and secondary pathology in pompe muscle "excessive autophagy" which is relevant to the therapy resistance No to Hattatsu 42(2): 114-116
Friis, B.; Thomsen, J. 1979: Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin Ugeskrift for Laeger 141(29): 1968-1972
Brunner, H.; Horak, W.; Grabner, G. 1976: Adverse effects of chenodeoxycholic-acid therapy Zeitschrift für Gastroenterologie. Verhandlungsband 9: 55-59
Olejárová, M. 2017: Adverse effects of biological therapy in rheumatology Vnitrni Lekarstvi 62(7-8): 605-612
Payk, T.R. 1979: Adverse effects and interactions in therapy with psychopharmaceuticals Medizinische Monatsschrift für Pharmazeuten 2(11): 336-340
Jorgensen, P.I. 1972: Adverse effects of local corticosteroid therapy Ugeskrift for Laeger 134(36): 1906
Schöpf, E. 1972: Adverse effects of external corticosteroid therapy Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 23(7): 295-301
Wig, N. 2002: Antiretroviral therapy: are we aware of adverse effects? Journal of the Association of Physicians of India 50: 1163-1171